{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T11:13:23Z","timestamp":1740136403953,"version":"3.37.3"},"reference-count":30,"publisher":"Informa UK Limited","issue":"11","license":[{"start":{"date-parts":[[2021,7,19]],"date-time":"2021-07-19T00:00:00Z","timestamp":1626652800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Drug Early Warning System","award":["3U01DA038360-04S2"],"award-info":[{"award-number":["3U01DA038360-04S2"]}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Substance Use &amp; Misuse"],"published-print":{"date-parts":[[2021,9,19]]},"DOI":"10.1080\/10826084.2021.1928213","type":"journal-article","created":{"date-parts":[[2021,7,19]],"date-time":"2021-07-19T12:01:50Z","timestamp":1626696110000},"page":"1576-1585","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":2,"title":["Toward a National System of Expanded Testing of Existing Urine Specimens: The Drug Outbreak Testing Service (DOTS)"],"prefix":"10.1080","volume":"56","author":[{"given":"Eric D.","family":"Wish","sequence":"first","affiliation":[{"name":"Center for Substance Abuse Research (CESAR), University of Maryland, College Park, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy S.","family":"Billing","sequence":"additional","affiliation":[{"name":"Center for Substance Abuse Research (CESAR), University of Maryland, College Park, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberley","family":"Heine","sequence":"additional","affiliation":[{"name":"Division of Forensic Toxicology, Armed Forces Medical Examiner System (AFMES), Dover, Delaware, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marwa F.","family":"Al-Nassir","sequence":"additional","affiliation":[{"name":"Department of Criminology and Criminal Justice, University of Maryland, College Park, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ebonie C.","family":"Massey","sequence":"additional","affiliation":[{"name":"Center for Substance Abuse Research (CESAR), University of Maryland, College Park, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret","family":"Hsu","sequence":"additional","affiliation":[{"name":"Center for Substance Abuse Research (CESAR), University of Maryland, College Park, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. Erin","family":"Artigiani","sequence":"additional","affiliation":[{"name":"Center for Substance Abuse Research (CESAR), University of Maryland, College Park, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2021,7,19]]},"reference":[{"unstructured":"Billing, A. S., Artigiani, E. E., Robinson, J., Adatsi, F. & Wish, E. D. (2017). Community drug early warning system (CDEWS-3): Washington, DC \u2013 Site 3 of 4. Office of National Drug Control Policy. Executive Office of the President.","key":"CIT0001"},{"unstructured":"Center for Substance Abuse Research (CESAR). (2018a). DOTS bulletin \u2013 Inaugural issue: Overview of the drug outbreak testing service pilot study. Retrieved November 5, 2020, from https:\/\/cesar.umd.edu\/sites\/cesar.umd.edu\/files\/dotsbulletin-issue1-june2018-methodology-final.pdf","key":"CIT0002"},{"unstructured":"CESAR. (2018b). Drug-positive urine specimens from uninsured or publicly insured residents of Montgomery County, Maryland, contain no fentanyl and few synthetic cannabinoids but do contain multiple drugs. Retrieved November 5, 2020, from https:\/\/cesar.umd.edu\/sites\/cesar.umd.edu\/files\/dotsbulletin-issue4-june2018-accesstobh-final.pdf","key":"CIT0003"},{"unstructured":"CESAR. (2018c). Methamphetamine: A regional drug crisis. Retrieved November 5, 2020, from https:\/\/cesar.umd.edu\/publicationprofile\/110","key":"CIT0004"},{"unstructured":"CESAR. (2018d). Methamphetamine, but no fentanyl, found in opiate-positive specimens from a Corpus Christi, Texas, Residential Treatment Center; Multiple drugs found in every specimen. Retrieved November 5, 2020, from https:\/\/cesar.umd.edu\/sites\/cesar.umd.edu\/files\/dotsbulletin-issue7-august2018-charliesplacetx-final.pdf","key":"CIT0005"},{"unstructured":"CESAR. (2018e). No fentanyl analogs but buprenorphine, naloxone, and marijuana detected in specimens from suspected users of fentanyl in Vermont. Retrieved November 5, 2020, from https:\/\/cesar.umd.edu\/sites\/cesar.umd.edu\/files\/dotsbulletin-issue6-july2018-aspenti-final.pdf","key":"CIT0006"},{"unstructured":"CESAR. (2018f). Uninsured opioid users admitted to medication-assisted treatment (MAT) program in Palm Beach County, Florida, found to be using many drugs in addition to opioids. Retrieved November 5, 2020 from https:\/\/cesar.umd.edu\/sites\/cesar.umd.edu\/files\/dotsbulletin-issue5-july2018-palmbeach-mat-rev-final.pdf","key":"CIT0007"},{"unstructured":"CESAR. (2019a). DOTS bulletins \u2013 De-identified urine testing. Retrieved November 5, 2020, from https:\/\/cesar.umd.edu\/ndews\/dots-bulletins-de-identified-urine-testing","key":"CIT0008"},{"unstructured":"CESAR. (2019b). Drugs detected in emergency department patients with suspected opioid overdose who did not respond to typical doses of naloxone. Retrieved November 5, 2020, from https:\/\/cesar.umd.edu\/sites\/cesar.umd.edu\/files\/dotsbulletin-issue10-december2019-ohsu-final.pdf","key":"CIT0009"},{"unstructured":"CESAR. (2019c). Gabapentin most common drug detected at Glen Burnie recovery house: \u201cGabapentin is replacing opioids and being misused.\u201d Retrieved November 5, 2020, from https:\/\/cesar.umd.edu\/sites\/cesar.umd.edu\/files\/dotsbulletin-issue9-december2019-steppingstones-final.pdf","key":"CIT0010"},{"unstructured":"CESAR. (2019d). Marijuana and opioids detected in a sample of specimens from gunshot wound victims. Retrieved November 5, 2020, from https:\/\/cesar.umd.edu\/sites\/cesar.umd.edu\/files\/dotsbulletin-issue11-december2019-pghc-final.pdf","key":"CIT0011"},{"unstructured":"CESAR. (2020). Emergency department drug surveillance (EDDS) system. Retrieved November 11, 2020, from https:\/\/cesar.umd.edu\/landing\/EDDS","key":"CIT0013"},{"unstructured":"Community Drug Early Warning System (CDEWS). (2020). Community drug early warning system (CDEWS). Retrieved November 5, 2020, from https:\/\/cesar.umd.edu\/cdews\/cdews-reports","key":"CIT0014"},{"doi-asserted-by":"publisher","key":"CIT0015","DOI":"10.1038\/s41380-020-00949-3"},{"unstructured":"Dezman, Z. D. W., Al-Nassir, M. F., Billing, A. S., Artigiani, E. E. & Wish, E. D. (2018). First DOTS study finds fentanyl and polydrug use in patients seen during opioid overdose spike in Baltimore \u2013 Higher doses of naloxone may be needed. Retrieved November 5, 2020, from https:\/\/cesar.umd.edu\/sites\/cesar.umd.edu\/files\/dotsbulletin-issue2-june2018-baltimore-midtown-final.pdf","key":"CIT0016"},{"unstructured":"Diversion Control Division (DCD). ( n.d.). DEA TOX drug enforcement administration toxicology testing program. Retrieved February 8, 2021, from https:\/\/www.deadiversion.usdoj.gov\/dea_tox\/index.html","key":"CIT0017"},{"doi-asserted-by":"publisher","key":"CIT0018","DOI":"10.1177\/0002716292521001006"},{"unstructured":"Greenwood, V. (2021). Scientists are trying to spot new viruses before they cause pandemics. Retrieved February 16, 2021, from https:\/\/www.nytimes.com\/2021\/02\/15\/health\/scientists-viruses.html","key":"CIT0019"},{"unstructured":"Hoffer, L., Schlosser, A. & Buckelew, K. (2019). NDEWS HotSpot report - Fentanyl: User beliefs and practices \u2013 Cleveland, Ohio. Retrieved February 3, 2021, from https:\/\/ndews.org\/publications\/hotspot-reports\/","key":"CIT0020"},{"doi-asserted-by":"publisher","key":"CIT0021","DOI":"10.1111\/1556-4029.14184"},{"unstructured":"Lopez, A. M. (2019). The co-use of methamphetamine and opioids among patients in treatment in Oregon, USA. Retrieved February 3, 2021, from https:\/\/ndews.org\/publications\/hotspot-reports\/","key":"CIT0022"},{"doi-asserted-by":"publisher","key":"CIT0023","DOI":"10.1080\/02791072.2017.1394508"},{"unstructured":"Moyer, P. (2019). Bio-Surveillance of non-fatal overdoses in Minnesota: A view a bit farther down the path-ology of substance use [Conference presentation]. Association of Public Health Laboratories (APHL) Annual Meeting, June 3. https:\/\/www.aphl.org\/conferences\/proceedings\/Documents\/Annual%20Meeting%202019\/10Moyer.pdf","key":"CIT0024"},{"unstructured":"Office for Human Research Protections. (2011). Attachment D: FAQ\u2019s terms and recommendations on informed consent and research use of biospecimens. Retrieved February 20, 2020, from https:\/\/www.hhs.gov\/ohrp\/sachrp-committee\/recommendations\/2011-october-13-letter-attachment-d\/index.html","key":"CIT0025"},{"unstructured":"Office of National Drug Control Policy. (2014). ADAM II 2013 annual report. Retrieved February 20, 2020, from https:\/\/obamawhitehouse.archives.gov\/sites\/default\/files\/ondcp\/policy-and-research\/adam_ii_2013_annual_report.pdf","key":"CIT0026"},{"doi-asserted-by":"publisher","key":"CIT0027","DOI":"10.1016\/j.drugalcdep.2019.107779"},{"unstructured":"Sorg, M. H., Wren, J. A., Stewart, K. & Cao, Y. (2017). Unintentional fentanyl overdoses in New Hampshire: An NDEWS hotspot analysis. Retrieved February 3, 2021, from https:\/\/ndews.org\/publications\/hotspot-reports\/","key":"CIT0028"},{"unstructured":"The Center for Forensic Science Research and Education (CFSRE). (2021). NPS discovery. Retrieved February 8, 2021, from https:\/\/www.npsdiscovery.org\/","key":"CIT0029"},{"doi-asserted-by":"publisher","key":"CIT0030","DOI":"10.3109\/10826089009071049"},{"unstructured":"Wish, E. D., Billing, A. S., Artigiani, E. E., Dezman, Z., Schwartz, B. & Pueschel, J. (2018). Drug early warning from re-testing biological samples: Maryland hospital study. Office of National Drug Control Policy. Executive Office of the President.","key":"CIT0031"}],"container-title":["Substance Use &amp; Misuse"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10826084.2021.1928213","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,4]],"date-time":"2021-08-04T22:28:27Z","timestamp":1628116107000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10826084.2021.1928213"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,19]]},"references-count":30,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,9,19]]}},"alternative-id":["10.1080\/10826084.2021.1928213"],"URL":"https:\/\/doi.org\/10.1080\/10826084.2021.1928213","relation":{},"ISSN":["1082-6084","1532-2491"],"issn-type":[{"type":"print","value":"1082-6084"},{"type":"electronic","value":"1532-2491"}],"subject":[],"published":{"date-parts":[[2021,7,19]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=isum20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=isum20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-07-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}